Racial differences in platelet survival time in patients with symptomatic coronary atherosclerosis.
- 1 March 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 3 (2) , 138-140
- https://doi.org/10.1161/01.atv.3.2.138
Abstract
Platelet survival times were studied in 40 patients (21 white and 19 black) with coronary artery disease and stable effort induced angina pectoris. The platelet survival times of 19 white controls (9.27 +/- 0.49 days; mean +/- SD) were not significantly different from those of 12 black controls (8.88 +/- 0.81 days), and the platelet survival times for 21 white patients with coronary artery disease (8.46 +/- 0.65 days) were lower than the times for both the white controls (p less than 0.01) and the combined control group (p less than 0.01). However, the difference between the mean platelet survival times of 19 black patients (9.22 +/- 0.68) and the control groups was not significant, and the difference between the mean platelet survival times of the 21 white patients and the 19 black patients was significant (p less than 0.01). Stepwise multiple linear regression analysis indicated that race was the most significant factor in predicting shortened platelet survival (r = 0.4783; p less than 0.01). It is concluded that racial background should be considered in the interpretation of platelet studies and that reported racial differences in the rate and extent of atherosclerotic lesions may be related to racial differences in platelet consumption.This publication has 16 references indexed in Scilit:
- Lack of Release of Platelet Factor 4 during Exercise-Induced Myocardial IschemiaNew England Journal of Medicine, 1981
- Lipid and Lipoprotein Distributions in Black AdultsJAMA, 1981
- Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy.Circulation, 1981
- Platelet Activation during Exercise-Induced Myocardial IschemiaNew England Journal of Medicine, 1980
- Platelet-suppressant therapy in patients with coronary artery diseaseJAMA, 1978
- Platelet and fibrinogen survival in coronary atherosclerosis: Response to medical and surgical therapyThe American Journal of Cardiology, 1977
- Platelet abnormalities in ischemic heart diseaseThe American Journal of Cardiology, 1973
- Cardiovascular disease in the tropics. IV. Coronary heart disease.BMJ, 1972
- Thrombokinetics in Idiopathic Thrombocytopenic Purpura*British Journal of Haematology, 1970
- CARDIOVASCULAR DISEASES IN THE WHITE AND NEGRO RACESThe Lancet Healthy Longevity, 1959